{"id":"NCT00403455","sponsor":"VA Office of Research and Development","briefTitle":"Monoamine Transporters Genotypes: Risk of PTSD and Related Comorbidities","officialTitle":"Monoamine Transporters Genotypes: Risk of PTSD and Related Comorbidities","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-10","primaryCompletion":"2011-07","completion":"2011-07","firstPosted":"2006-11-23","resultsPosted":"2014-12-08","lastUpdate":"2018-07-02"},"enrollment":38,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["PTSD"],"interventions":[{"type":"DRUG","name":"Paroxetine","otherNames":["Paxil"]}],"arms":[{"label":"Paroxetine Arm","type":"OTHER"}],"summary":"Dr. Wang's merit review is aimed at providing a better understanding of the relationship between SLC6A3/SLC6A4 and the mental health of veterans exposed to high levels of combat stress, specifically focusing on PTSD symptoms, related co-morbidities, treatment outcomes and seeks new approaches to therapy for our Veteran population.","primaryOutcome":{"measure":"Clinician Administered PTSD Scale (CAPS)","timeFrame":"12 weeks","effectByArm":[{"arm":"Paroxetine Arm","deltaMin":-21.72,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":38},"commonTop":["Minor Nausea"]}}